New drug tested for rare blood disorder when standard treatment fails
Disease control
Completed
This study tested a new drug called OMS906 for people with paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disease. It specifically looked at patients who weren't getting good results from their current standard treatment, ravulizumab. Researchers gave 12 participants two…
Phase: PHASE2 • Sponsor: Omeros Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC